LakeShore Biopharma Co Profit Margin

As of the most recent data (March 2024), LSB shows a profit margin of -66.9%. That compares with 12.79% in the prior-year period — down 623.2% year over year. That is below the sector sector average of 21.44%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LSB's profit margin is now -66.9% (was 12.79%) — a 623.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co is outperforming or lagging.

The its sector sector average profit margin is about 21.44%. LakeShore Biopharma Co is at -66.9%, which is lower that average. That is roughly 412.1% below the sector mean. Use the comparison chart on this page to see how LSB stacks up against individual peers as well.

That compares with 12.79% in the prior-year period — down 623.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare LakeShore Biopharma Co with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has LakeShore Biopharma Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -66.9%) with ownership activity and broader fundamentals.